News-Medical.Net on MSN
New antibody drug conjugates can transform early HER2-positive breast cancer treatment
In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback